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hronic Total Occlusion Angioplasty
n the United States
. Aaron Grantham, MD,* Steven P. Marso, MD,* John Spertus, MD, MPH,*
ohn House, MS,* David R. Holmes JR, MD,† Barry D. Rutherford, MD*
ansas City, Missouri; and Rochester, Minnesota
oronary chronic total occlusions (CTOs) are commonly encountered complex lesions identiﬁed in 15%
f all patients referred for coronary angiography. Chronic total occlusion remains the most powerful
redictor of referral for coronary bypass surgery. The beneﬁts of CTO percutaneous coronary interven-
ion (PCI) include symptom relief, improved left ventricular function, and potentially a survival advan-
age associated with success when compared with failed CTO-PCI. Data from the NCDR (National Car-
iovascular Data Registry) suggest that CTO-PCI attempt rates in the U.S. have not changed over the
ast 5 years despite signiﬁcant advances in techniques and technology, some of which we review
ere. Additionally, these data highlight a major disparity in attempt rates based on operator PCI vol-
me. Remaining barriers to attempting CTO-PCI in the U.S. include operator inexperience, the percep-
ion of increased risk of CTO-PCI, and ﬁnancial disincentives to operators and hospitals. To overcome
perator inexperience, participation in CTO clubs, the invitation of guest operators, and a dedicated
TO day can be implemented at institutions committed to learning advanced CTO-PCI techniques so
hat operators can overcome the barriers and offer patients access to percutaneous therapy when it is
linically indicated. (J Am Coll Cardiol Intv 2009;2:479–86) © 2009 by the American College of
ardiology Foundation(
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Coronary chronic total occlusions (CTOs) are com-
only encountered complex lesions identified in 15%
o 30% of all patients referred for coronary angiogra-
hy (1,2). Chronic total occlusions have been referred
o as the final frontier in interventional cardiology (3).
his sentiment relates to the difficulty and complexity
f recanalizing them with percutaneous techniques.
See page 487
The difficulty in treating CTOs percutaneously is
eflected in the observation that success rates are
ower for CTO percutaneous coronary intervention
rom *Saint Luke’s Health System’s Mid-America Heart Institute,
niversity of Missouri Kansas City School of Medicine, Kansas City,
issouri; and the †Mayo Graduate School of Medicine, Mayo Clinic,
ochester, Minnesota. Financial support provided by the family of Chad
immons. Dr. Carlo Di Mario acted as Guest Editor for this paper.e
anuscript received October 2, 2008; revised manuscript received
ebruary 17, 2009, accepted February 24, 2009.PCI) than for subtotal stenoses (70% vs. 98%) (4,5).
hus, this common and complex coronary occlusion
emains the strongest independent predictor of refer-
al for coronary artery bypass graft surgery (1). Ad-
itionally, CTO-PCI attempt rates are surprisingly
ow relative to estimates of angiographic suitability
2), and in 1 series (6), the frequency of CTO-PCI
elative to all PCI is decreasing. The purpose of this
eview is to summarize the benefits of CTO-PCI,
eview current practice patterns in an effort to identify
ommon barriers to attempting CTO-PCI among
perators in the U.S., summarize emerging tech-
iques, and suggest potential options for learning
hese techniques so that operators can overcome the
arriers and offer patients access to percutaneous
herapy when it is clinically indicated.
enefits of CTO-PCI
TO-PCI has the potential to offer patients sev-
ral benefits including symptom relief, improve-
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480ent in left ventricular function, and better long-term
urvival.
ymptom relief. Successful CTO-PCI is associated with im-
roved symptom relief when compared with unsuccessful
TO-PCI (7). In the TOAST-GISE (Total Occlusion An-
ioplasty Study–Società Italiana di Cardiologia Invasiva) trial,
TO-PCI success was associated with 86% angina-free sur-
ival, whereas CTO-PCI failure was associated with 70%
ngina-free survival (p 0.008). Cheng et al. (8) demonstrated
hat 76% of patients with CTO who were treated with PCI
xperienced an improved angina classification, whereas 17% of
atients who were not treated with PCI improved (p 0.05).
o study to date has used a reliable instrument such as the
eattle Angina Questionnaire to quantify the benefits of
TO-PCI on quality-of-life outcomes.
eft ventricular function. Successful CTO-PCI has been
emonstrated to result in improved left ventricular function
nd attenuated left ventricular remodeling as long as vessel
atency is maintained (9–11). Cheng et al. (8) used contrast-
nhanced magnetic resonance imaging to demonstrate that
wall thickening in the myocar-
dium subtended by a CTO vessel
improved with CTO-PCI over
the ensuing 6 months (55% to
68%). Others have suggested that
patients who have never experi-
enced a clinically evident myocar-
dial infarction (MI) (9) or patients
who have had an MI but have
residual ischemia, viability, or hi-
bernating myocardium are most
likely to benefit from CTO-PCI
(12,13). Identifying these latter
patients can be difficult. Cardiac
ositron emission computed tomography (14), cardiac
ontrast-enhanced magnetic resonance imaging (8,15), and
obutamine echocardiography (14) appear to be promising
maging techniques to assess viability and may be useful in
etermining the appropriateness of PCI.
urvival advantage. The presence of an untreated CTO is
rognostically important. Hannan et al. (16) used the New
ork State PCI registry to determine the association of
ompleteness of revascularization after PCI and survival. After
bbreviations
nd Acronyms
ART  controlled
ntegrade and retrograde
racking
TO  chronic total
cclusion
I  myocardial infarction
CDR  National
ardiovascular Data Registry
CI  percutaneous
oronary intervention
Table 1. Single-Center Studies of Survival in CTO-PCI Success Versus Failu
Author (Ref. #) n Time Frame
Suero et al. (5) 2,007 1980–1999
Hoye et al. (18) 874 1999–2002
Aziz et al. (19)* 199 2000–2004
Olivari et al. (7)† 369 2003
Valenti et al. (20) 486 2003–2006
*Includes only the propensity-matched cohort. †Cardiac death among patients discharged withouCTO chronic total occlusion; PCI percutaneous coronary intervention.djustment for baseline differences, the mortality rate was
igher when incomplete revascularization was due to an
ntreated CTO than a subtotal stenosis (hazard ratio: 1.36,
5% confidence interval [CI]: 1.12 to 1.66; p  0.05).
ultivessel disease is associated with an increased risk of
ortality in the setting of acute MI. The majority of this risk
s attributable to the presence of a CTO (17).
The survival advantage associated with successful versus
nsuccessful CTO-PCI has been demonstrated in unselected
atients in 5 studies (5,7,18–20) (Table 1). A 3.8% to 8.4%
bsolute reduction in mortality was associated with successful
ersus failed CTO-PCI. Only 1 recent study (4) has failed to
dentify an association between successful CTO-PCI and
mproved survival.
Taken together, these studies support the hypothesis that
uccessful CTO-PCI may be life-prolonging, a hypothesis that
ertainly deserves further testing in the form of a randomized
ontrolled trial. Without such a trial, controversy will persist
ver the survival benefit of CTO-PCI. Until then, the decision
o intervene in the absence of symptoms or heart failure
emains difficult and controversial. Chronic total occlusion
CI in asymptomatic patients with normal left ventricular
unction and no or only mild ischemia in the distribution of the
ccluded vessel cannot be justified. Only in the case of
rognostically significant ischemia or heart failure with signif-
cant viability should CTO-PCI be considered in the absence
f symptoms.
hat Are the Barriers to Performing CTO-PCI?
espite conferring benefits, CTO-PCI attempt rates remain
urprisingly low and unchanged over the past 5 years in the
.S. Historically, investigators estimated the frequency of
TO-PCI as a function of all PCIs performed. With that
etric, 5% of all PCIs performed were done for CTO (6), but
he true CTO attempt rate is unknown. The attempt rate can
e approximated using both the cardiac catheterization and the
CI modules of the NCDR (National Cardiovascular Data
egistry) database, which is restricted to U.S. centers (21). The
TO-PCI attempt rate among 388 participating centers is
efined as the number of CTO-PCI attempts divided by the
umber of eligible CTOs discovered at the time of angiogra-
hy. Between January 2004 and March 2005, 645,520 patients
Follow-Up Time Survival in Success Versus Failed CTO-PCI
Cumulative 10 yr 73.5 vs. 65.1%, p  0.001
4.47  2.69 93.5 vs. 88.0%, p  0.020
Cumulative 2 yr 98.0 vs. 94.2%, p  0.045
1 yr 98.9 vs. 96.4%, p  0.039
Cumulative 4 yr 91.6 vs. 87.4%, p  0.025
rdial infarction or coronary artery bypass grafting.re
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481nderwent diagnostic angiography, of which 35,643 were
iscovered to have a CTO and no indication for noncoronary
ardiac surgery (e.g., valvular heart disease). A total of 4,828
atients ultimately underwent attempted CTO-PCI, yielding
national attempt rate of 13.6%. Among these patients, 6,523
18.3%) were referred for bypass surgery during the same
ospitalization. These analyses were extended to subsequent
ersions of the NCDR. As shown in Figure 1, the PCI attempt
ate for CTOs has not changed over the past 5 years, despite
ajor advances in procedural technique.
There may be patient- or operator-related barriers to CTO-
CI that explain this surprisingly low attempt rate. There were
,632 operators from NCDR version 3.04 included in this
nalysis, 1,388 were low volume (75 PCIs per year), 941
ntermediate volume (75 to 200 PCIs per year), and 301 high
olume (200 PCIs per year). Table 2 lists the multivariate
redictors of CTO-PCI attempt operators. Patient character-
stics such as decreasing age, absence of diabetes, and single-
essel disease were associated with an increased CTO-PCI
ttempt operators. After adjustment for these differences, low-
nd intermediate-volume operators were one-half as likely as
igh-volume operators to perform CTO-PCI.
Figure 2 demonstrates the mean attempt rate in each
olume strata. Not only was the mean attempt rate of all
ow-volume operators lower than that of intermediate- and
igh-volume operators, but also the standard deviation of the
ean attempt rate was highest in the low-volume group.
hese observations suggest less variance in attempt rates
mong high-volume operators. Additionally, low-volume op-
rators were more likely to refer patients with CTO for
oronary artery bypass graft surgery (19.1%, 15.9%, and 14.0%,
Figure 1. National Attempt Rate Over Time
Annual CTO-PCI attempt rate among 388 institutions from the NCDR
(National Cardiovascular Data Registry) database. ^Includes data from Janu-
ary 1, 2004, through March 31, 2005. *Includes data from January 1, 2007,
through October 31, 2007. CTO  chronic total occlusion; PCI  percutane-
ous coronary intervention.ow, intermediate, and high, respectively; p  0.001).We also found that the vast majority of operators in the U.S.
erform less than 200 PCIs per year. Therefore, the efforts of
ndividual high-volume operators willing to embark on a more
ggressive CTO program may be diluted by the majority of
perators who are less enthusiastic about attempting these
ifficult cases (22).
In addition to operator experience, there are several barriers
o CTO-PCI that may contribute to operator reluctance to
ttempt these complex lesions. These include: 1) the difficulty
n crossing CTOs with wires; 2) unique complications such as
essel perforation, contrast nephropathy, radiation injury, and
Table 2. Independent Predictors of CTO-PCI Attempt
Odds Ratio 95% CI
Age by 10-yr decrease 1.34 1.31–1.38
Race: other vs. Caucasian 1.23 1.12–1.35
Nondiabetic 1.25 1.17–1.34
No prior MI 1.48 1.38–1.59
Creatinine 2.0 mg/dl 1.93 1.57–2.38
Stress test result
Positive vs. negative 1.18 1.07–1.31
Symptom status
Unstable angina vs. asymptomatic 1.78 1.63–1.96
Unstable angina vs. atypical chest pain 1.66 1.49–1.85
Unstable angina vs. stable angina 1.34 1.24–1.45
EF 40% 1.26 1.15–1.38
Single-vessel vs. multivessel disease 3.07 2.87–3.28
CTO location
LAD vs. RCA 1.58 1.46–1.70
Operator volume
Low vs. intermediate 0.59 0.54–0.65
Low vs. high 0.50 0.46–0.55
Intermediate vs. high 0.85 0.79–0.91
CI confidence interval; EF ejection fraction; LAD left anterior descending; MImyocardial
infarction; RCA right coronary artery; other abbreviations as in Table 1.
Figure 2. Mean Operator Attempt Rate for CTO-PCI
Attempt rate for CTO-PCI among low-, intermediate-, and high-volume
operators in the NCDR. *p  0.05. Abbreviations as in Figure 1.
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482he potential for loss of collaterals; and 3) economic disincen-
ives, a problem unique to U.S. operators.
ire-crossing difﬁculties. Substantial intellectual and finan-
ial resources have been invested in the effort to overcome the
ifficulty in crossing CTOs with a wire. Technology such as
pecially designed wires (23) and techniques such as parallel
ires, retrograde approaches (24,25), and the subintimal track-
ng and re-entry technique, among others (26), have been
escribed and demonstrated in a multitude of educational
orums. A variety of devices have been developed in an effort to
vercome wire-crossing difficulties (27–31). These are largely
sed as niche devices and will not be extensively reviewed here.
Beginning in 1994, wire design improvements were made
nd later resulted in better crossing success with antegrade
echniques at select centers (32). These wire design im-
rovements included a central core with an outer coil that
mproved torque responsiveness, tapering of the wire tip
rom 0.014 to 0.009 inches, the addition of hydrophilic
olymer coatings, plastic jackets, and variable tip stiffness.
ome of these dedicated CTO wires, which vary in stiffness
rom floppy (0.5 g) to extremely stiff (12 g), are now
vailable in the U.S. (Table 3).
omplications associated with CTO angioplasty. The overall
isk of CTO-PCI has been examined in several studies.
ompared with a matched cohort of patients undergoing
on–CTO-PCI (N  2,007), we found that those under-
oing CTO-PCI (N 2,007) had similar in-hospital major
dverse cardiac event rates, including death (1.3% vs. 0.8%,
 0.13), Q-wave MI (0.5% vs. 0.6%, p  0.67), urgent
oronary artery bypass graft surgery (0.7% vs. 1.1%, p 
.25), and combined major adverse cardiac events (3.8% vs.
.7%, p  0.90). The occurrence of dissection was more
requent in the CTO group (17.8% vs. 13.3%, p  0.008),
Table 3. Currently Available Commonly Used CTO Wires in the U.S.
Manufacturer Wire Tip Stiffness
Asahi/Abbott Whisper 1
Medium 3
Fielder 1
Fielder FC 1
Fielder XT 1
Miracle Bros. 3, 4.5, 6, 1
Conﬁanza 9, 12
Conﬁanza Pro 9, 12
Pilot 50, 150, 200 1.6, 3, 4.5
Medtronic Persuader 3, 6
Persuader 9 9
Boston Scientiﬁc Choice PT 2
PT Graphix 3–4
Cordis Shinobi 2
Shinobi Plus 4
Abbreviation as in Table 2.ut in this study stenting was performed in only 7% of cases w5). Despite these data, controversy remains surrounding
isks that may be uniquely prevalent in CTO-PCI. These
isks include coronary perforation, contrast nephropathy,
adiation exposure, and collateral loss.
Coronary perforation may be more likely to occur in CTO
han in subtotally occluded vessels. Among the cohort of 4,828
atients who underwent CTO-PCI from the NCDR version
.04, the perforation rate for CTO-PCI was 0.9%. The
erforation rate among an unselected cohort of patients un-
ergoing PCI was 0.2% (33).
Perforation of the coronary artery has several potential
amifications including intramyocardial hematoma, fistula for-
ation into a cardiac chamber, coronary vein, or a great vessel,
imited pericardial hematoma, and cardiac tamponade. Despite
elatively high perforation rates compared with non–CTO-
CI perforation rates, in-hospital mortality in the NCDR
roup was only 0.7%. This compares favorably with mortality
ates observed in a contemporary PCI registry, where in-
ospital mortality ranged between 0.1% and 3.0% and was
elated to left ventricular function (34).
Because of the increased potential for perforation, glyco-
rotein IIb/IIIa inhibitors and direct thrombin inhibitors that
ave no antidote should not be used when attempting CTO-
CI until a wire is safely delivered to the true lumen of the
istal vessel beyond the CTO. The utility of bailout glyco-
rotein IIb/IIIa inhibition in this setting is unproven. Addi-
ionally, we recommend the use of unfractionated heparin,
hich is immediately reversible upon identification of perfo-
ation. Finally, to avoid distal wire perforation, softer-tipped
ydrophobic wires should be exchanged for the stiffer hydro-
hilic CTO wires as soon as the true lumen of the distal vessel
as been reached.
Operators performing CTO-PCI should be experienced
Shaft and Tip Diameter (inches) Hydrophilicity
0.014 Yes
0.014 No
0.014 Yes
0.014–0.009 Yes
0.014 Yes
0.014 No
0.014–0.009 No
0.014–0.009 Yes
0.014 Yes
0.014 Yes
0.014–0.009 Yes
0.014 Yes
0.014 Yes
0.014 Yes
0.014 Yes(g)
2ith a variety of tools needed to deal with coronary
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483erforation. When a wire perforation occurs in smaller distal
ranches, the branch can be occluded with wire coils,
icrospheres, a small piece of thrombus, or a small piece of
he patient’s subcutaneous fat injected through an end-hole
atheter. Similarly, if a wire perforation has occurred in the
roximal vessel or within the CTO, the proximal vessel can
imply be reoccluded with these materials. A perforation
reated by a wire exit within the occluded segment can often be
emedied by prolonged balloon inflation and conventional
tenting. If that fails, a covered stent can be used to seal the
erforation (33) or surgical correction can be performed by
versewing the vessel and bypassing the CTO.
The risk of contrast nephropathy is related to contrast
olume. Compared with PCI of subtotal stenoses, CTO-
CI is associated with greater contrast volume use. Despite
his, we did not find an increased risk of renal failure with
TO-PCI versus PCI of subtotal stenoses in matched
atients (5). This discrepancy may reflect patient selection
r better use of renal protective interventions in patients
ith CTO. In fact, renal insufficiency, defined as serum
reatinine 2.0 mg/dl, was a strong predictor of deferral of
TO-PCI in the NCDR registry version 3.04 (odds ratio of
ttempted CTO-PCI: 0.51, 95% CI: 0.42 to 0.64; p 
.001). Aggressive measures to prevent contrast nephropa-
hy should be employed in high-risk patients.
The risk of radiation injury is related to the dose of
adiation during PCI. Procedure and fluoroscopy times are
igher for CTO than non–CTO-PCI. Suzuki et al. (35)
ound that mean fluoroscopy time for CTO-PCI among 75
atients was 45  25 min and the maximum entrance skin
ose was 3.2  2.1 Gy. These numbers varied widely
etween institutions, suggesting that standardized interven-
ions to limit radiation exposure should be considered (36).
perators should attempt to minimize radiation exposure to
atients and catheterization staff. This can be accomplished
y careful procedure planning, collimation, fluoroscopy at
5 rather than 30 frames/s, frequent movement of the image
ntensifier angle, maximizing the distance from the radia-
ion source, maximizing imaging in the right anterior
blique views, and accessory lead shielding. Even though it
s an imprecise measure of total radiation exposure, fluoros-
opy time should be tracked throughout the procedure.
luoroscopy times exceeding 60 min should be avoided. We
ecommend that patients exposed to fluoroscopy times 60
in or total dose over 5 Gy receive consultation from a
ermatologist or radiation oncologist familiar with the
anagement of radiation dermatitis.
Collateral function in patients with CTO has been exten-
ively studied by Werner and colleagues (37–39). They ele-
antly demonstrated collateral functional loss by identifying a
0% reduction in mean peak recruitable collateral flow imme-
iately after CTO-PCI (37). In subsequent studies, they
emonstrated that only 18% of patients maintain recruitable
ollateral function adequate to prevent ischemia in the event of gn acute reocclusion (stent thrombosis or subsequent acute MI
nvolving the previously dilated CTO vessel), whereas patients
ith chronic reocclusion (restenosis) had sufficient collateral
edevelopment to maintain myocardial viability (38).
The importance of collateral loss, however, may be upstaged
y the observation that only 7% of patients had collateral flow
eserve sufficient to prevent stress-induced ischemia, and as
any as 33% of patients have physiologic evidence of coronary
teal (39). These limitations of collateral function lead Werner
t al. (37–39) to conclude that even in patients with “well-
eveloped” collaterals, anti-ischemic benefit may be derived
rom CTO-PCI.
conomic disincentives to CTO-PCI. The CTO-PCI proce-
ure is labor- and resource-intensive. Unpublished data from
ur institution show that the typical CTO-PCI requires twice
he procedure (81 min vs. 44 min) and fluoroscopy (40 min vs.
7 min) time as non–CTO-PCI. The average balloon and
tent utilization is 2.4 and 1.9 per CTO case compared with
.5 and 1.7 per non-CTO case, respectively. Given the benefits
f CTO-PCI, U.S. payers should reimburse operators and
nstitutions committed to CTO-PCI at a level commensurate
ith the degree of difficulty, the amount of time, and resources
equired relative to non–CTO-PCI.
TO-PCI Techniques
ecent advances in CTO-PCI techniques that have broadened
CI indications and improved success rates can be categorized
nto antegrade and retrograde techniques.
It is also generally agreed by CTO experts that every case of
TO-PCI where contralateral collaterals exist should be done
ith bilateral injections to allow for simultaneous antegrade
nd retrograde filling of the target vessel (40).
ntegrade techniques. Many experts recommend the tech-
ique of using wires of graduated tip stiffness for those learning
TO-PCI techniques (41). For those CTOs selected for an
ntegrade approach, the operator should begin with a soft
ipped, tapered hydrophilic wire (Fielder XT, Abbott Vascular,
nc., Abbott Park, Illinois) in an effort to traverse the CTO
hrough microchannels. The crossing of a CTO through
icrochannels can be facilitated by contrast injection into the
roximal cap through the end of a balloon or microcatheter
42). If penetration of the proximal cap or access through a
icrochannel is unsuccessful, progressive wire tip stiffness (3-,
-, and 9-g wires) should be tried. If these fail, a tapered,
ydrophilic 9- or 12-g wire should be used. It is noteworthy
hat the wire tip “stiffness” is related to the distance the tip
xtends beyond the end hole of the balloon or catheter. A 3-g
ire can perform similar to 12-g wire if it is used5 mm from
he end hole of a balloon. A 12-g wire will perform with
esistance of 30 to 40 g when it is used within 5 mm of the end
ole of a balloon or catheter. No consensus exists over the best
ethod for an initial antegrade attempt. We prefer theraduated approach just outlined for beginning CTO operators
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484nd recommend that only after significant experience (50
imple CTOs) (44) with graduated wires should operators skip
o or start with stiffer wires.
If any of the above mentioned wires is inadvertently ad-
anced into a subintimal space, it should be left in place and a
econd wire of the same caliber and stiffness should be used. It
s recommended that a slightly different tip angle be used for
his second wire. This approach is called the “parallel wire
echnique” (44). When the second wire enters a subintimal
pace, the first wire is pulled back and an attempt is made to
dvance this wire into the true lumen. This maneuver is known
s the “see-saw wire” technique. On occasion, a third wire may
e used to penetrate the cap of the CTO between 2 other
ires. It is important to evaluate the course of the subintimal
ire in orthogonal views before advancing a second wire.
Operators at the Kurashiki Central Hospital in Kurashiki,
apan, have demonstrated their ability to improve wire-
rossing success along a continuum of time (from 62% to 85%)
hen these techniques were adopted at their center (32).
For operators learning CTO-PCI, these antegrade tech-
iques using a stepwise wire approach should be predomi-
antly used. Although there are a host of CTO niche devices
vailable (28,45), our bias is toward mastering these founda-
ional antegrade wire techniques first.
etrograde techniques. Collaterals channels can be used in a
etrograde approach to CTO-PCI. Collaterals can take a
eptal, atrial, or epicardial course. The ideal channels take a
eptal course to the recipient vessel, are straight, and have a
isible connection on routine nonselective coronary angiogra-
hy. Even though angiographic evidence of communicating
ollaterals exists in approximately 50% of cases, many of these
ill not provide access to the distal CTO vessel. Conversely,
any angiographically invisible CTO channels exist and can
e unmasked only by selective tip injections through an
nd-hole catheter or simple probing of proximal septal chan-
els with a soft hydrophilic wire.
Operators learning the retrograde approach should perform
elective tip injections of candidate collaterals using end-hole
atheters such as the Transit (2.5- and 2.1-F, Cordis Corp.,
arren, New Jersey), Excelsior (2.0-F, Boston Scientific,
atick, Massachusetts), Prowler (1.7-, 1.9-, and 2.3-F, Cordis
orp.), or Finecross (1.8-F, Terumo Medical Corp., Somerset,
ew Jersey) or use the recently approved Corsair channel
ilator (Asahi Intecc, Nagoya Aichi, Japan), all of which are
ow available in the U.S. Selective injections provide visual-
zation of the recipient vessel with much less contrast than
onselective injections in the donor artery and are therefore
seful even when the antegrade approach is planned. Gaining
xperience in collateral channel identification and interpreta-
ion with this exercise is one way to develop the basic skills
equired for retrograde CTO-PCI.
Atrial and epicardial collateral channels are potentially useful
or access to the distal CTO cap. These tend to be thicker
alled, less elastic, and tortuous. They are therefore more mrone to dissection and rupture. Because of the complexity and
ncreased risk of using these channels, atrial and epicardial
ollateral access to the distal CTO cap should be among the
ast techniques to be mastered by retrograde CTO operators.
The commonly used techniques for distal CTO cap pene-
ration are the true retrograde, kissing wire, controlled ante-
rade and retrograde tracking (CART), and reverse CART
echniques with or without a knuckle wire. In the true
etrograde technique, the retrograde wire is advanced through
he lesion and threaded into the antegrade guide. The retro-
rade wire can then be trapped in the antegrade guide to
acilitate balloon advancement through the lesion. It should be
mphasized that an operator should never advance or retract a
etrograde wire without catheter protection of the septal
hannels. Once balloon dilation of the lesion is complete, a
econd wire can be advanced via the antegrade guide past the
TO and used for final treatment. The steps involved in
erforming the true retrograde technique are detailed in the
nline Appendix. Many perturbations of this technique exist
ncluding the exteriorization of the retrograde wire via the
ntegrade guide. These advanced techniques are beyond the
cope of this review and are best learned by attending dedicated
TO training courses such as those offered by the U.S.,
uropean, and Japanese CTO clubs. The Corsair channel
ilator (Asahi Intecc), recently approved by the Food and Drug
dministration, will largely supplant the need to dilate septal
ollateral channels and perform retrograde dilation of CTO
esions.
When retrograde wire crossing of the CTO into the true
umen is not possible, alternatives include the kissing wire,
ART, and reverse CART techniques. Kissing wire technique
s executed by penetrating the proximal cap with 1 wire via the
ntegrade guide and penetrating the distal cap with another
ire via the retrograde guide. The 2 wires meet in the middle
f the lesion, and the antegrade wire is then advanced along the
ath of the retrograde wire or vice versa to complete lesion
rossing.
When the retrograde wire passes into the subintimal space,
he CART technique can be employed. A balloon is inflated in
he retrograde subintimal space, creating a dissection. The
ntegrade wire is then used to reenter the true lumen, often
ith intravascular ultrasound guidance. Variations of this
echnique (the reverse CART) have also been employed.
electing the initial approach to CTO-PCI. No consensus
xists for selecting an initial approach to a CTO (antegrade vs.
etrograde). The most common reason to use retrograde
echniques among experienced CTO operators is failure to
ucceed using the antegrade approach (65%). If failure with the
ntegrade approach is imminent and fluoroscopy time is 30
in, the change can be made ad hoc. In the event that greater
ime has been used, the patient should be brought back for a
taged attempt at least 48 h after the first attempt. Certain
ubsets of patients, including those with long lesions (20
m), ostial occlusions, extreme tortuosity, severe calcification,
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485nd small or poorly visualized distal vessels may also be selected
or a primary retrograde approach.
raining CTO-PCI Operators
raining in CTO-PCI requires a substantial commitment of
ime and resources by operators and institutions. One approach
o training less experienced operators in the advanced tech-
iques of CTO-PCI is to dedicate a day to perform CTO-PCI
nd have more experienced operators directly mentor less
xperienced operators during cases. Such a “CTO-Day” pro-
ram can be enhanced by a visit from experts in the retrograde
echniques. This type of continuously mentored practice im-
rovement has been very effective at our institution. The
ommitment of time and resources for a CTO-Day program
ay not be possible at some institutions, and the alternative of
isiting American, European, or Japanese CTO centers or
TO club meetings for focused training is an option (22).
raining volume recommendations have been outlined by the
uropean CTO club (43), and we concur with those recom-
endations, although the volume requirements are somewhat
rbitrary. It is appropriate that operators who do not wish to
ake on these difficult and time-consuming procedures refer
ifficult cases to colleagues at centers where these procedures
re performed on a routine basis.
When non-CTO operators wish to embark on CTO-PCI
raining, they should select CTOs with favorable characteris-
ics followed by more difficult lesions according to the recom-
endations of the European CTO club (43). Favorable CTO
haracteristics include those described by Dong et al. (46), such
tapered proximal CTO cap, CTO length of 15 mm,
roximal vessel angulation of 45°, and single versus multiple
otal occlusions within the target vessel. Only after achieving
olumes recommended by the European CTO club (50 simple
TOs) should CTO trainees embark on learning the more
ifficult techniques and using niche devices in carefully selected
ases, preferably with the direct supervision of an experienced
perator. It is typical for success rates to again decline as
perators take on more difficult procedures. To maintain
xpertise, the European CTO club recommends performance
f at least 50 CTO-PCIs per year per operator. Maintaining
hese volumes requires hospitals and groups to restrict CTO-
CI procedures to approximately 1 CTO operator for every
00 PCIs performed.
onclusions
n summary, at experienced centers, CTO-PCI is safe, results
n symptom relief, improvement in left ventricular function,
nd perhaps improved long-term survival. Disparity in CTO-
CI attempt rates between low- and high-volume interven-
ionalists suggests that similar patients do not have equal access
o therapeutic strategies due to system-based barriers. These
arriers could be overcome through formalization of training indvanced techniques, encouragement of referral, standardiza-
ion of practice patterns, and reimbursement commensurate
ith the time and resources needed to effectively treat these
omplex patients percutaneously.
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APPENDIX
or the steps involved in performing true retrograde approach, please see
he online version of this article.
